BOSTON, June 29 (Reuters) - A 10th patient taking Biogen Idec Inc's Tysabri has developed a potentially deadly brain infection since the multiple sclerosis drug was reintroduced to the market in July ...

Medicines that reshape or tamp down immune responses may be life-changing for patients with cancer and autoimmune disorders, but in some cases they can awaken a dormant virus and unleash a deadly ...

NEWPORT BEACH, Calif., March 16, 2023 /PRNewswire/ -- In an editorial in the journal Frontiers in Neurology, two leading multiple sclerosis (MS) experts are advocating for genetic testing to identify ...

Investigational apitegromab met its primary endpoint of motor function improvement in a phase III trial of spinal muscular atrophy, Scholar Rock announced. Masked tapering with a targeted behavioral ...

Please provide your email address to receive an email when new articles are posted on . Use of a genetic risk test for patients considering immunosuppressive therapies associated with development of ...